Pluristem Therapeutics - PLUR Total Company Value-to-Revenue Ratio

Pluri Inc (PLUR) - corporate logo

The EV/Sales multiple history demonstrates the market valuation of Pluri Inc. (PLUR), where this metric equals 31773.97. Management is currently adapting the cell platform for the agricultural sector and foodtech. A team of experienced bioengineers is developing innovative placenta-based drugs. The technological foundation is provided by Israeli plants featuring autonomous power supplies and strict climate control within clean zones.

PLUR Pluri: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

PLUR (pluri-biotech.com): analytical breakdowns and indicator data

Fundamental valuation:PLUR - Pluri Inc
Brand item of Pluri Inc.

The EV/Sales metric determines the enterprise value of a business, including net debt relative to sales volume, allowing for an assessment of the real value of assets without distortions from leverage. By analyzing current EV/Sales trends, an investor can identify if an asset is overbought, which is critical for Pluri Inc. (PLUR), whose capitalization relies on the patent protection of cell technologies but is limited by commercialization risks in medicine and foodtech.

Competitor analysis

ASND: Enterprise Value-to-Revenue Ratio|MDGL: EV/Sales Multiple|CORT - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Rhythm Corp|Akero Corp (AKRO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio metsera.com (MTSR)|Company Value to Revenue moonlaketx.com MLTX|EV/Sales Multiple CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Company Value to Revenue Ratio|SLNO - Enterprise Value-to-Revenue Ratio|Amicus Pharma (FOLD) - Company Value to Revenue|ETNB: EV/Sales Multiple|AGIO - Total Company Value-to-Revenue Ratio|Company Value to Revenue GPCR|Enterprise Value-to-Revenue Multiple MiMedx MDXG|Enterprise Value-to-Revenue Ratio Rezolute Corp (RZLT)|Company Value to Revenue Lexicon Corp LXRX|Enterprise Value-to-Revenue Ratio MBX Biosciences, Inc. MBX|EV/Sales Multiple altimmune.com ALT|AARD - Enterprise Value-to-Revenue Ratio|Sagimet - Enterprise Value-to-Revenue Coefficient|BioAge Labs Inc. (BIOA) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - EV/Sales Multiple|GUTS: Business Value to Revenue|Enterprise Value-to-Revenue Ratio vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio synlogictx.com SYBX|LPCN: Company Value to Revenue Ratio|MTNB - Enterprise Value-to-Revenue Ratio|Spruce Biosciences, Inc. (SPRB) - Company Value to Revenue|GLTO: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - EV/Sales Multiple|Organovo Corp (ONVO) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Radius Recycling (RDUS)